Compass Pathways has published a post hoc analysis of its [...]
Compass Pathways has reported positive six-month results from its second [...]
EPIK Biosciences launches with ketamine pipeline targeting mental health, chronic pain and addiction
EPIK Biosciences has launched as a new psychedelic drug development [...]
Incannex Healthcare has said its PSX-001 oral synthetic psilocybin programme [...]
As psychedelic-assisted therapies move closer to mainstream psychiatric care, Cybin, [...]